Concepedia

Dawn E. Smilek

DE

Statistics

Publications

25

Citations

1.8K

H-Index

17

Active since

1980

Affiliations

University of California, San Francisco(Current)

Immune Tolerance Network

National Institute of Allergy and Infectious Diseases

Feinstein Institute for Medical Research

Stanford University

Dawn E. Smilek is an author at University of California, San Francisco specializing in immunology, medicine, and autoimmunity.

ORCID

Top concepts

Publications per year

1980–2023

25

Publications

25

Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy

David C. Wraith, Dawn E. Smilek, Dennis J. Mitchell et al. · Cell · 1989 · 391 citations

, , +12

Predictors of Long‐Term Renal Outcome in Lupus Nephritis Trials: Lessons Learned from the Euro‐Lupus Nephritis Cohort

Maria Dall’Era, Miriam G. Cisternas, Dawn E. Smilek et al. · Arthritis & Rheumatology · 2015 · 305 citations

Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis

Yemil Atisha‐Fregoso, Susan Malkiel, Kristina M. Harris et al. · Arthritis & Rheumatology · 2020 · 197 citations · Full text

A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis.

Dawn E. Smilek, David C. Wraith, Suzanne Hodgkinson et al. · Proceedings of the National Academy of Sciences · 1991 · 165 citations · Full text

, , +22

A polyalanine peptide with only five native myelin basic protein residues induces autoimmune encephalomyelitis.

Anand M. Gautam, Cecelia I. Pearson, Dawn E. Smilek et al. · The Journal of Experimental Medicine · 1992 · 84 citations · Full text

, , +18

1–5 of 25